ArticleSkeletal radiology2026
Textural analysis as an instrument to detect differences on sacral chordoma MRI post-radiation therapy.
Article in Skeletal radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSacral chordoma is a rare bone tumor frequently treated with pre-surgical radiation; however, treatment response is difficult to determine based on imaging features of conventional MRI. We hypothesized that MRI texture analysis may be capable of demonstrating the effects of radiation therapy. MATERIALS AND
methodsWe retrospectively examined pre- and post-radiation therapy MRI of patients with sacral chordomas. Firstly, the regions of interest delimiting the largest cross-sectional area of the tumors on coronal T1-weighted images were compared between pre- and post-radiation therapy MRI. Texture analysis features were extracted, analyzed, and classified. Secondly, all the coronal T1-weighted images were compared using large language models (LLM) to extract texture features.
resultsA total of 22 patients received pre-surgical radiation therapy (RT) and obtained pre- and post-radiation therapy MRI. A linear discriminant analysis model of the top 10 texture analysis features classified correctly 79.5% of chordomas pre- vs. post-treatment. The top 4 textural features had 81.8% sensitivity and 77.2% specificity in differentiating pre- vs. post-radiation chordomas, with a receiver operator area under the curve (AUC) of 84.5% (P = 0.003). Three texture features were related to pixel relationships and one to variations in pixel gray level (wavelet). The second approach using all the coronal-T1 images analyzing gray-level co-occurrence matrix (GLCM) features revealed a significant increase in correlation after RT (mean pre, 0.92; mean post, 0.95; P = 0.016).
conclusionTexture analysis is a quantitative tool capable of differentiating pre- and post-radiotherapy chordomas and may provide biomarkers of treatment response.
Indexed as
Identifiers
41217469What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.